Quest Diagnostics debuts a new blood test for myeloma MRD, offering NGS-level sensitivity and a less invasive alternative to ...

Quest Diagnostics (NYSE: DGX), a leading provider of diagnostic information services, today announced the launch of a novel ...

Nicholas Richardson, DO, at Precision for Medicine, breaks down minimal residual disease and MRD negativity as FDA end points for faster myeloma approvals. Under this framework, MRD negativity is ...

CellaVision AB (CLVSF) reports robust sales growth and strategic advancements despite regional challenges and margin pressures.

Cancer cases among people under 50 are rising sharply in India, doctors warn, stressing early diagnosis, awareness of symptoms and timely treatment after rare, life-threatening cases in young adults ...

As the world marks World Cancer Day today, cancer is often thought of as a disease that mostly affects older people. But now it has become a formidable adversary that knows no age ...

The top court cites lack of scientific evidence, ethical violations, and regulatory failures that have pushed desperate families toward unproven interventions for patients with ASD ...

University of York researchers have received a £2.5 million boost from Cancer Research UK to advance pioneering work into ...

The former RTÉ newsreader reflects on illness, ageing, community, dreams and why hope still shapes his future ...

Cancer is often thought of as a disease that mostly affects older people. But now it has become a formidable adversary that knows no age limits. A study published in JAMA Network Open ...

Bone health relies on a balance between osteoblasts (builders) and osteoclasts (recyclers). Peak bone mass occurs in early adulthood; deficiencies during this window amplify fracture risks later in ...

The recovery process takes months, hence why the hospital’s Tuesday announcement came roughly five months later.